Natural Co-Occurrence of Mycotoxins in Foods and Feeds and Their in vitro Combined Toxicological Effects.
Smith MC, Madec S, Coton E, Hymery N. · 2016
Read Natural Co-Occurrence of Mycotoxins in Foods and Feeds and Their in vitro Combined Toxicological Effects. by Smith MC, Madec S, Coton E, Hymery N. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4848621.txt.
Introduction
Marie-Caroline Smith and co-authors reviewed how mold toxins, called mycotoxins, occur together in food and animal feed, and what mixed exposure does. Most past work and most rules treat one toxin at a time. Yet surveys worldwide find several toxins in the same grain lots. The review sums up 127 reported combinations in cereals and their products.
The most common pairings join aflatoxins with fumonisins, or deoxynivalenol with zearalenone, among others. Lab tests of mixes show effects that can cancel, add up, or multiply, shifting with species, cell type, dose, and time. Rules that judge each toxin alone may thus miss real risk, and the review presses for mix-aware testing.
Catalog record
| CREATOR | Smith MC, Madec S, Coton E, Hymery N. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Natural Co-Occurrence of Mycotoxins in Foods and Feeds and Their in vitro Combined Toxicological Effects By Marie-Caroline Smith, Stéphanie Madec, Emmanuel Coton, Nolwenn Hymery, Sven Dänicke Published in: Toxins DOI: 10.3390/toxins8040094 ABSTRACT Abstract Some foods and feeds are often contaminated by numerous mycotoxins, but most studies have focused on the occurrence and toxicology of a single mycotoxin. Regulations throughout the world do not consider the combined effects of mycotoxins. However, several surveys have reported the natural co-occurrence of mycotoxins from all over the world. Most of the published data has concerned the major mycotoxins aflatoxins (AFs), ochratoxin A (OTA), zearalenone (ZEA), fumonisins (FUM) and trichothecenes (TCTs), especially deoxynivalenol (DON). Concerning cereals and derived cereal product samples, among the 127 mycotoxin combinations described in the literature, AFs+FUM, DON+ZEA, AFs+OTA, and FUM+ZEA are the most observed. However, only a few studies specified the number of co-occurring mycotoxins with the percentage of the co-contaminated samples, as well as the main combinations found. Studies of mycotoxin combination toxicity showed antagonist, additive or synergic effects depending on the tested species, cell model or mixture, and were not necessarily time- or dose-dependent. This review summarizes the findings on mycotoxins and their co-occurrence in various foods and feeds from all over the world as well as in vitro experimental data on their combined toxicity. Keywords: mycotoxins, foodstuffs, regulations, co-occurrence, combined toxicological effects 1. INTRODUCTION Mycotoxins are secondary fungal metabolites mainly produced by species from the Aspergillus, Penicillium, and Fusarium genera. These toxins are found all around the world as natural contaminants in numerous commodities of plant origin, especially in cereals grains, but also in nuts, oilseeds, fruits, dried fruits, vegetables, cocoa and coffee beans, wine, beer, as well as herbs and spices. Mycotoxins can also be found in animal-derived food if animals eat contaminated feed, namely meat, eggs, milk, and milk derivatives [1,2]. Mycotoxin production, especially on grains, is highly dependent on pre and/or postharvest environmental factors (e.g., temperature and moisture content). Climate represents the key factor in mycotoxin and fungal occurrence. Mycotoxins are climate-dependent compounds but several factors can affect their presence, such as bioavailability of micronutrients, insect damage making it a complex and multifactor phenomenon [3]. These metabolites are usually subdivided into field mycotoxins, produced on cereal crops before or immediately after harvest mainly by Fusarium spp., and storage mycotoxins, primarily secreted by Aspergillus and Penicillium spp. during commodity drying and storage [1]. Mycotoxin ingestion may induce various chronic and acute effects on humans and animals, such as hepatotoxic, genotoxic, immunosuppressive, estrogenic, nephrotoxic, teratogenic, and/or carcinogenic effects [1,4]. Moreover, mycotoxins are not completely eliminated during food processing operations and can contaminate finished processed food products [5,6]. Their worldwide occurrence in various food and feeds poses a major risk for human and animal health and, as a consequence, causes economic losses [1]. Although these economic costs are impossible to estimate accurately, the United States Food and Drug Administration (FDA) evaluated, based on computer modeling, that in the USA the potential economic costs of crop losses due to mycotoxin contaminations average $932 million per year [7]. The FAO (Food and Agriculture Organization of the United Nations) estimated that 25% of the world’s crops are affected by mycotoxins each year, with annual losses of around 1 billion metric tons of food and food products (2007). Among the thousands of fungal secondary metabolites currently known, only a few groups of mycotoxins are important from the safety and economic points of view; namely aflatoxins (AFs), mainly produced by Aspergillus species; ochratoxin A (OTA), produced by Aspergillus and Penicillium species, and zearalenone (ZEA), fumonisins (FUM) and trichothecenes (TCTs) (especially deoxynivalenol (DON)), primarily produced by many Fusarium species [8,9,10]. Moreover, several species from the Fusarium genus can produce other mycotoxins with toxicological properties such as beauvericin (BEA), enniatins (ENNs), and moniliformin (MON), a group of lesser-studied toxins called emerging mycotoxins [11] (a non-exhaustive list of mycotoxin producing Aspergillus, Penicillium and Fusarium species, split into eight groups, is provided in Table 1). Even if these mycotoxin-producing fungi differ according to ecological conditions, it is important to emphasize that mycotoxins are found all over the world in foodstuffs and feedstuffs due to trade in these commodities that contributes to their worldwide dispersal. Moreover, Table 1 shows that one mycotoxin can be produced by several fungi, and that a fungus can produce several mycotoxins. [Table: Some mycotoxins of interest and their fungal source, with primary food and feed hosts and endemic regions. References: [1,2,4,24,25,26,27,28,29,30,31,32].] Several authors have shown an interest in cellular mechanisms and cellular toxicity in response to mycotoxin exposure. After ingestion by the consumer, the intestinal epithelium is the first host defense barrier against mycotoxins. However, although these cells are the first to be exposed to mycotoxins and at higher doses than other tissue cells, studies on the effect of mycotoxin mixtures on the gastrointestinal tract are scarce. Grenier and Appelgate [12] summarized in a recent review findings following major mycotoxin exposure (AFs, OTA, DON, T2, ZEA, and FUM) on digestive and absorptive functions, intestinal defense and microbiome composition. Briefly, they highlighted the large variability of mycotoxin bioavailability according to the considered mycotoxins and animal species. For example, the authors reported that more than 80% of AFs are absorbed within the gastrointestinal tract regardless of the non-ruminant species (via passive transport), whereas absorption of other major mycotoxins (TCT, OTA, or FUM) may vary from 1% to 60% (via passive transport by simple diffusion for OTA or via the paracellular route for DON). Moreover, several mycotoxins have been shown to undergo entero-hepatic circulation. This makes the mycotoxins available again via the bile in the entero-hepatic cycle, resulting in reabsorption and a prolonged retention time in the gastrointestinal tract. Intestinal metabolism in the gut epithelium and by the gut microbial population, limits the toxic effects of mycotoxins within the gastrointestinal tract. In particular, due to rumen microorganisms, ruminants are able to convert many mycotoxins into non-toxic metabolites before absorption, whereas for monogastrics, mycotoxin intestinal biotransformation takes place predominantly in the large intestine and thus provides little detoxification prior to absorption. However, little is known about the intestinal absorption and bacterial metabolism of the metabolites. Nevertheless, a recent in vitro study showed that the derivative 15-ADON caused the highest paracellular permeability and chemokine secretion compared to DON and 3-ADON in human intestinal cells Caco-2 [13]. Even if commensal microbiota is a key player in the detoxification against mycotoxins and their derivatives, it is important to note the potential of mycotoxins to enhance the toxic effects of intestinal pathogens and to change the intestinal microbiota balance by increasing the number of aerobic bacteria and thereby acting as a potential risk factor for chronic inflammatory diseases [12]. Because of their occurrence and toxicity, major mycotoxins (i.e., AFs, OTA, ZEA, FUM, and DON) are the focus of legal regulations or guidance in many countries. The Joint Expert Committee on Food Additives (JECFA), a scientific advisory body of the World Health Organization (WHO) and the FAO, evaluates mycotoxin risks. In the United States and the European Union, regulatory and recommended guidance for mycotoxins are issued by the FDA and the European Commission (EC) advised by the European Food Safety Authority (EFSA), respectively. To protect animal and human consumers, these regulations